Methods of using dyes in association with nucleic acid staining or detection and associated technology
1 Assignment
0 Petitions
Accused Products
Abstract
Methods of using dyes and associated technology are provided. A dye, such as a monomeric dye or a dimeric dye, may be used in a nucleic acid gel staining application and/or a nucleic acid detection application. Such a dye and a salt that comprises an anion that is associated with a strong acid and a cation that is associated with a strong base may be used in such an application. A dimeric dye, such as a dimeric dye capable of forming a hairpin-like structure, may be used to stain and/or detect nucleic acids via a release-on-demand mechanism. A dimeric dye having low background fluorescence in the absence of nucleic acids and high fluorescence in the presence of nucleic acids, upon binding therewith, may be used to stain and/or detect nucleic acids.
45 Citations
22 Claims
-
1. A compound having the formula:
-
2. The compound of claim 1, wherein BRIDGE has the formula:
-
-L1-[A1-(CH2)α
—
]a[A2-(CH2)β
—
]b[A3-(CH2)γ
—
]c[A4-(CH2)δ
—
]d[A5-(CH2)ε
—
]e[A6-(CH2)ζ
—
]f[A7-(CH2)η
—
]g[A8-(CH2)θ
—
]h[A9-(CH2)ι
—
]i-A10-L2-wherein each of L1 and L2, independently, is a moiety comprising a single bond;
a polymethylene unit having 1 carbon to 12 carbons, inclusive, optionally comprising at least one hetero atom selected from N, O and S;
or an aryl optionally comprising at least one hetero atom selected from N, O and S;each of A1, A2, A3, A4, A5, A6, A7, A8, A9, and A10, independently, is a nucleic-acid-binding-enhancing-group (NABEG);
a branched alkyl optionally comprising at least one hetero atom selected from N, O and S;
or at least one saturated 5- or 6-membered ring, optionally comprising at least one hetero atom selected from N, O and S;
or an aryl group optionally comprising at least one hetero atom selected from halogens, N, O, and S;each of α
, β
, γ
, δ
, ε
, ζ
, η
, θ
, and ι
, independently, is zero or an integer from 1 to 20, inclusive; andeach of a, b, c, d, e, f, g, h, and i, independently, is zero or an integer from 1 to 20, inclusive.
-
-
3. The compound of claim 2, wherein BRIDGE has the formula:
-
—
(CH2)x—
C(═
O)NH—
(CH2)α
—
[O—
(CH2)β
]b—
[O—
(CH2)γ
]c—
NH(O═
C)—
(CH2)x—wherein each x, independently, is an integer selected from 1 to 11, inclusive;
a is an integer selected from 2 to 20, inclusive;
each of β and
γ
, independently, is 2 or 3;
b is zero or an integer from 1 to 20, inclusive; and
c is zero or 1.
-
-
4. The compound of claim 1, wherein each of Q1 and Q2 is a phenanthridium dye of Formula I:
-
5. The compound of claim 4, wherein x is 5;
- α and
γ
are the same and are 2 or 3;
β
is 2; and
b is 0, 1, 2, or 3.
- α and
-
6. The compound of claim 4, wherein the compound has the structure:
-
7. The compound of claim 1, wherein each of Q1 and Q2 is an asymmetric cyanine dye, and wherein each of Q1 and Q2 dye constituents independently has a structure of Formula II:
-
8. The compound of claim 7, wherein each of Q1 and Q2 has the structure:
-
9. The compound of claim 7, wherein the compound has the structure:
-
10. The compound of claim 1, wherein each of Q1 and Q2 is independently an acridine dye of Formula III:
-
11. The compound of claim 4, wherein each R1 is H;
- R2 is H;
R3 represents where BRIDGE attaches to the structure;
each R6 is —
CH3; and
each R7 is —
CH3.
- R2 is H;
-
12. The compound of claim 11, wherein the compound has the structure:
-
13. The compound of any one of claims 1-12, wherein ψ
- is I−
or Cl−
.
- is I−
-
14. A kit for determining presence or absence of nucleic acid in a sample, the kit comprising:
- a compound according to any one of claims 1-13;
optionally, a buffer; and
information concerning use of the kit.
- a compound according to any one of claims 1-13;
-
15. The compound of claim 2, wherein the Bridge comprises a weakly basic constituent.
-
16. The compound of claim 15, wherein the Bridge comprises an aryl group comprising at least one Nitrogen atom.
-
17. The compound of claim 16, wherein the Bridge comprises a pyridine group, pyrazine group, triazole group, or tetrazole group.
-
18. The compound of claim 2, wherein at least one of A1, A2, A3, A4, A5, A6, A7, A8, A9, and A10 independently comprises an aryl group;
- the aryl group optionally comprising at least one hetero atom selected from halo, N, O, and S.
-
19. The compound of claim 18, wherein at least one of A1, A2, A3, A4, A5, A6, A7, A8, A9, and A10 independently comprises an aryl group;
- the aryl group comprising at least one Nitrogen atom.
-
20. The compound of claim 19, wherein at least one of A1, A2, A3, A4, A5, A6, A7, A8, A9, and A10 independently comprises a pyridine group, a pyrazine group, a triazole group, or a tetrazole group.
-
21. The compound of claim 20, wherein at least one of A1, A2, A3, A4, A5, A6, A7, A8, A9, and A10 independently comprises a triazole group.
-
22. The compound of claim 21, wherein at least one of A1, A2, A3, A4, A5, A6, A7, A8, A9, and A10, independently comprises a 1,2,3-triazole group.
Specification